The global CAR T-cell therapy market is witnessing rapid growth, driven by increasing prevalence of cancer and positive regulatory policies. Key players in the market are investing in innovation to enhance their product portfolio and cater the growing requirement for effective cancer treatments. Furthermore, advancements in CAR T-cell therapy tech